Methylprednisolone was first introduced by Pfizer Inc in its drug Medrol on Approved Prior to Jan 1, 1982. 15 different companies have introduced drugs containing Methylprednisolone.
About Veterinary Methylprednisolone
Methylprednisolone is used in drugs marketed by 2 different companies:
Cronus Pharma Specialities India Private Ltd, Zoetis Inc.
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List
Clinical Trials
Recent Clinical Trials on
Methylprednisolone:
Sometimes companies keep conducting clinical trials even after the drug's approval to discover new formulations, methods of use, or new treatment indications, so they could file for additional patents or receive regulatory exclusivity extensions, such as pediatric exclusivity, potentially delaying generic competition. Based on these recent clinical trials, generic companies need to consider the potential for new intellectual property or regulatory hurdles. These strategic moves by the drug owner might delay generic substitution or lead to additional sales of the brand drug, even after patent expiry.
Several generic applications have been filed for Methylprednisolone. The first generic version for Methylprednisolone was by Heather Drug Co Inc and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by Amneal Eu Ltd and was approved on Sep 21, 2021.
Given below is the list of companies who have filed for
Methylprednisolone generic, along with the locations of their manufacturing plants worldwide.
